companydata.dkcompanydata.dk

Ranger Biotechnologies A/S: Financial statements 2023

CVR: 32280404

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

Ranger Biotechnologies A/S (CVR 32280404) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,653,810 and a net result of DKK 1,431,531 compared with DKK 371,913 the year before. That is a decrease of 76.7% compared with the year before. Equity in the 2023 report amounted to DKK 2,692,785. The solvency ratio was 96.9%.

Gross Profit
DKK 1,653,810
Profit/Loss
DKK 1,431,531
Equity
DKK 2,692,785
Total Assets
DKK 2,777,533
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-1.7M1.4M2.7M0
2022-7.1M372K1.3M11
2021-5.7M172K889K9
2020-2.4M0717K3
2019-591K-12.7M717K2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Ranger Biotechnologies A/S: The 2022 annual report is outJun 23, 2023

Ranger Biotechnologies A/S has published its annual report for 2022. Gross profit came to DKK 7,096,093, and the net result was DKK 371,913.

About Ranger Biotechnologies A/S

Ranger Biotechnologies A/S is a Danish company of the type Aktieselskab based in Odense SØ, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named MIRRX THERAPEUTICS A/S and MIRX THERAPEUTICS A/S. The management consists of Hans Thorleif Møller. The board consists of Christina Møller Udesen (chair), Hans Thorleif Møller, Kasper Tvede Larsen and Søren Tvede Larsen. The company is owned by QUERDENKER ApS and Outlate Holding ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -409,444 and a net result of DKK -843,419 compared with DKK -1,138,092 the year before. Equity in the 2025 report amounted to DKK 711,273.

Source: annual report 2025, Danish Business Authority